Infliximab induced chilblain lupus in a patient with rheumatoid arthritis

J Rheumatol. 2005 Apr;32(4):760-1.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / immunology
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / immunology
  • Arthritis, Rheumatoid / complications
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / pathology
  • Autoantibodies / blood
  • Chilblains / complications
  • Chilblains / etiology*
  • Chilblains / pathology
  • Female
  • Humans
  • Immunocompromised Host
  • Infliximab
  • Lupus Erythematosus, Cutaneous / complications
  • Lupus Erythematosus, Cutaneous / etiology*
  • Lupus Erythematosus, Cutaneous / pathology
  • Middle Aged
  • Raynaud Disease / complications
  • Raynaud Disease / etiology
  • Raynaud Disease / pathology

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Autoantibodies
  • Infliximab